NDC 0378-9735

Zovirax

Acyclovir

Zovirax is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Acyclovir.

Product ID0378-9735_26685154-50b5-4edf-a2fd-334f0cb4e2ca
NDC0378-9735
Product TypeHuman Prescription Drug
Proprietary NameZovirax
Generic NameAcyclovir
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2018-10-05
Marketing End Date2023-02-28
Marketing CategoryNDA / NDA
Application NumberNDA019909
Labeler NameMylan Pharmaceuticals Inc.
Substance NameACYCLOVIR
Active Ingredient Strength200 mg/5mL
Pharm ClassesDNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC Exclude FlagN

Packaging

NDC 0378-9735-73

473 mL in 1 BOTTLE (0378-9735-73)
Marketing Start Date2018-10-05
Marketing End Date2023-02-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0378-9735-73 [00378973573]

Zovirax SUSPENSION
Marketing CategoryNDA
Application NumberNDA019909
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-10-05

Drug Details

Active Ingredients

IngredientStrength
ACYCLOVIR200 mg/5mL

OpenFDA Data

SPL SET ID:7cc087ad-51af-4c6a-87ef-72636b67321f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 307730
  • 201903
  • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    NDC Crossover Matching brand name "Zovirax" or generic name "Acyclovir"

    NDCBrand NameGeneric Name
    0187-0993Zoviraxacyclovir
    0187-0994Zoviraxacyclovir
    0378-9735ZoviraxAcyclovir
    40076-949ZOVIRAXZOVIRAX
    40076-991ZOVIRAXZOVIRAX
    40076-953ZOVIRAXZOVIRAX
    40076-945ZOVIRAXZOVIRAX
    42254-149ZOVIRAXZOVIRAX
    0093-3630Acycloviracyclovir
    0093-8940AcyclovirAcyclovir
    0093-8943AcyclovirAcyclovir
    0093-8947AcyclovirAcyclovir
    0143-9657AcyclovirAcyclovir
    0143-9658AcyclovirAcyclovir
    0168-0825acycloviracyclovir
    0378-8700Acycloviracyclovir
    0378-8712AcyclovirAcyclovir
    0440-6030AcyclovirAcyclovir
    0440-7033acycloviracyclovir
    0472-0082AcyclovirAcyclovir
    0591-1159Acycloviracyclovir
    0713-0630AcyclovirAcyclovir
    0904-5789ACYCLOVIRACYCLOVIR
    0904-5790acycloviracyclovir
    10544-039Acycloviracyclovir
    10544-089Acycloviracyclovir
    10544-101AcyclovirAcyclovir

    Trademark Results [Zovirax]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ZOVIRAX
    ZOVIRAX
    98588614 not registered Live/Pending
    Rising Pharma Holdings, Inc.
    2024-06-06
    ZOVIRAX
    ZOVIRAX
    85161519 not registered Dead/Abandoned
    GlaxoSmithKline LLC
    2010-10-26
    ZOVIRAX
    ZOVIRAX
    75282515 2223200 Dead/Cancelled
    Glaxo Wellcome Inc.
    1997-04-28
    ZOVIRAX
    ZOVIRAX
    73203076 1141502 Live/Registered
    Burroughs Wellcome Co.
    1979-02-05

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.